AU2972701A - 3-aminopyrazole inhibitors of cyclin dependent kinases - Google Patents

3-aminopyrazole inhibitors of cyclin dependent kinases

Info

Publication number
AU2972701A
AU2972701A AU2972701A AU2972701A AU2972701A AU 2972701 A AU2972701 A AU 2972701A AU 2972701 A AU2972701 A AU 2972701A AU 2972701 A AU2972701 A AU 2972701A AU 2972701 A AU2972701 A AU 2972701A
Authority
AU
Australia
Prior art keywords
inhibitors
aminopyrazole
cyclin dependent
dependent kinases
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2972701A
Other languages
English (en)
Inventor
Mark E Salvati
Spencer David Kimball
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2972701A publication Critical patent/AU2972701A/xx
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2972701A 2000-02-07 2001-01-23 3-aminopyrazole inhibitors of cyclin dependent kinases Pending AU2972701A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18060900P 2000-02-07 2000-02-07
PCT/US2001/002208 WO2001057034A1 (en) 2000-02-07 2001-01-23 3-aminopyrazole inhibitors of cyclin dependent kinases

Publications (1)

Publication Number Publication Date
AU2972701A true AU2972701A (en) 2001-08-14

Family

ID=22661092

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001229727A Ceased AU2001229727B2 (en) 2000-02-07 2001-01-23 3-aminopyrazole inhibitors of cyclin dependent kinases
AU2972701A Pending AU2972701A (en) 2000-02-07 2001-01-23 3-aminopyrazole inhibitors of cyclin dependent kinases

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001229727A Ceased AU2001229727B2 (en) 2000-02-07 2001-01-23 3-aminopyrazole inhibitors of cyclin dependent kinases

Country Status (11)

Country Link
US (2) US6482842B2 (xx)
EP (1) EP1268472B1 (xx)
JP (1) JP2003522174A (xx)
AT (1) ATE279410T1 (xx)
AU (2) AU2001229727B2 (xx)
CA (1) CA2399274A1 (xx)
DE (1) DE60106409T2 (xx)
DK (1) DK1268472T3 (xx)
ES (1) ES2228905T3 (xx)
PT (1) PT1268472E (xx)
WO (1) WO2001057034A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2223922T1 (sl) 2000-04-25 2016-04-29 Icos Corporation Inhibitorji humane fosfatidil-inositol 3-kinazne delta izoforme
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
UA76977C2 (en) 2001-03-02 2006-10-16 Icos Corp Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
WO2004044226A2 (en) * 2002-11-12 2004-05-27 The Board Of Trustees Of The University Of Illinois Induction of cellular senescence by cdk4 disruption for tumor supression and regression
JP2006526015A (ja) * 2003-05-02 2006-11-16 エラン ファーマシューティカルズ,インコーポレイテッド 炎症疾患治療のためのブラジキニンb1受容体アンタゴニストとしての4−ブロモ−5−(2−クロロ−ベンゾイルアミノ)−1h−ピラゾール−3−カルボン酸アミド誘導体および関連化合物
WO2005016888A1 (ja) * 2003-08-13 2005-02-24 Bf Research Institute, Inc. アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤
US20070275918A1 (en) * 2003-11-07 2007-11-29 The Board Of Trustees Of The University Of Illinois Induction of Cellular Senescence by Cdk4 Disruption for Tumor Suppression and Regression
HUE030950T2 (en) 2004-05-13 2017-06-28 Icos Corp Quinazolinones as 3-kinase delta inhibitors of human phosphatidylinositol
EP1899304A1 (en) * 2005-05-23 2008-03-19 Arena Pharmaceuticals, Inc. 5-amino-1h-pyrazole-3-carboxylic acid derivatives as agonists for the g-protein coupled receptor (gpcr) rup38 for the treatment of metabolic-related disorders thereof
CA3092449A1 (en) 2008-11-13 2010-05-20 Gilead Calistoga Llc Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
MX2012000817A (es) 2009-07-21 2012-05-08 Gilead Calistoga Llc Tratamiento para desordenes del higado con inhibidores pi3k.
PE20141792A1 (es) 2012-03-05 2014-12-07 Gilead Calistoga Llc Formas polimorficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluor-3-fenilquinazolin-4(3h)-ona
CA2934531C (en) 2013-12-20 2020-02-25 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
EP3083623A1 (en) 2013-12-20 2016-10-26 Gilead Calistoga LLC Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
CN106459005A (zh) 2014-06-13 2017-02-22 吉利德科学公司 磷脂酰肌醇3‑激酶抑制剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416683A (en) * 1980-09-16 1983-11-22 Eli Lilly And Company Benzamides, compositions and agricultural method
JPS6033552A (ja) * 1983-08-04 1985-02-20 Fuji Photo Film Co Ltd カラ−画像形成方法
DE3575130D1 (de) * 1984-05-12 1990-02-08 Fisons Plc Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung.
JPH0743522B2 (ja) * 1985-07-05 1995-05-15 コニカ株式会社 5―アミノ―1h―ピラゾール系化合物を用いる写真用マゼンタカプラーの合成方法
JPH01258695A (ja) * 1988-04-07 1989-10-16 Yamanouchi Pharmaceut Co Ltd (ピラゾリルアミノ)メチレンビス(ホスホン酸)誘導体及びその医薬
WO1993005044A1 (en) * 1991-09-03 1993-03-18 Yamanouchi Pharmaceutical Co.,Ltd. Pyrazolotriazole derivative
JPH06210063A (ja) * 1993-01-14 1994-08-02 Kousaku Ishikawa パチンコゲーム機における持ち玉返却機構
ES2219670T3 (es) * 1994-11-10 2004-12-01 Millennium Pharmaceuticals, Inc. Utilizacion de compuestos de pirazola para el tratamiento de la glomerulonefritis, cancer, ateroesclerosis o restenosis.
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
DE19744676A1 (de) 1997-10-10 1999-04-15 Forschungszentrum Borstel Zent Kombinationspräparate für die Therapie von Tumoren
GB9904932D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
HN2000000051A (es) 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
PE20010306A1 (es) 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
US6958333B1 (en) 1999-07-26 2005-10-25 Banyu Pharmaceutical Co., Ltd. Biarylurea derivatives
US6387900B1 (en) * 1999-08-12 2002-05-14 Pharmacia & Upjohn S.P.A. 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
ES2249270T3 (es) 1999-08-12 2006-04-01 Pharmacia Italia S.P.A. Derivados de 3(5)-aminopirazol, procedimiento para su preparacion y su uso como agentes antitumorales.

Also Published As

Publication number Publication date
AU2001229727B2 (en) 2004-10-14
JP2003522174A (ja) 2003-07-22
CA2399274A1 (en) 2001-08-09
DE60106409D1 (de) 2004-11-18
US20010047019A1 (en) 2001-11-29
EP1268472A1 (en) 2003-01-02
EP1268472B1 (en) 2004-10-13
WO2001057034A1 (en) 2001-08-09
US6610724B2 (en) 2003-08-26
ES2228905T3 (es) 2005-04-16
US6482842B2 (en) 2002-11-19
DE60106409T2 (de) 2006-02-02
PT1268472E (pt) 2005-01-31
DK1268472T3 (da) 2004-12-06
ATE279410T1 (de) 2004-10-15
US20030018058A1 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
YU4903A (sh) N-/5-///5-alkil-2-oksazolil/metil/tio/-2-tiazolil/ karboksamidni inhibitori ciklin zavisnih kinaza
PL364884A1 (en) N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
NZ517758A (en) Pyrazolopyrimidines useful as therapeutic agents
WO2006004833A3 (en) Pyrrolotriazine kinase inhibitors
MXPA02005844A (es) Inhibidores de cinasas de proteina.
AU2972701A (en) 3-aminopyrazole inhibitors of cyclin dependent kinases
TW200505924A (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
MY130363A (en) "pyrrole substituted 2-indolinone protein kinase inhibitors"
HK1065033A1 (en) Thiazole compounds useful as inhibitors or proteinkinases
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
MXPA03006863A (es) Derivados de oxazolilpirazol com inhibidores de cinasa.
MXPA04001114A (es) Derivados de aminoindazol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
IL173348A (en) Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs
MXPA04000920A (es) Derivados de aminoisoxazol activos como inhibidores de la cinasa.
RS20060004A (xx) DERIVATI PIROLO(3,4-c)PIRAZOLA AKTIVNI KAO INHIBITORI KINAZE
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
MY125768A (en) N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
ATE396986T1 (de) Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
CY1110666T1 (el) Πυραζολοπυριμιδινες καταλληλες για θεραπεια καρκινικων νοσων
ATE287886T1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer
MXPA04005809A (es) Inhibidores de proteinas quinasas.
NO20026032D0 (no) Farnesyltransferasehemmende 1,2-annelert kinolinenantiomer
ECSP003821A (es) Inhibidores de n-(5(((5-alquil-2-oxazolil)metil)tio)-2-tiazolil)-carboxamida de cinasas dependientes de ciclina